Zimistobart
Zimistobart (BMS-986315) is a fully human IgG1 antibody that targets NKG2A. Zimistobart can be used for the study of non-small cell lung cancer (NSCLC) . The isotype control for Zimistobart can refer to Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
CAS Number
[2829290-06-2]
Product Name Alternative
BMS-986315
UNSPSC
12352203
Target
Checkpoint Kinase (Chk)
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[Zimistobart]
References & Citations
[1]Fisher JG, et al. Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity. Oncotarget. 2024 Jul 17;15:501-503.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
495273 100 µL
USP22 (Ubiquitin Carboxyl-terminal Hydrolase 22, Ubiquitin Specific Peptidase 22)
Ask
View Details 
